Cite
MLA Citation
Bardur Sigurgeirsson et al.. “Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study.” Journal of dermatological treatment, vol. 33, 2022, pp. 1718–1726. http://access.bl.uk/ark:/81055/vdc_100156456578.0x000031